XRTX — XORTX Therapeutics Share News
0.000.00%
Last trade - 00:00- CA$5.54m
- CA$4.16m
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering
Brief: Xortx Announces Closing Of Acquisition Of Vectus Kidney Anti-Fibrotic Asset
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Xortx Therapeutics To Consolidate Shares 1-For-5 Effective April 6, 2026
Brief: XORTX Provides Update On Acquisition Of Renal Anti-Fibrotic Therapeutic Program From Vectus Biosystems
Brief: Vectus Biosystems Signed A Binding Term Sheet With Xortx Therapeutics Inc
Brief: XORTX Therapeutics Provides Update On FDA Type B Meeting Request
Brief: XORTX Announces Update For Discussion With The FDA
Brief: XORTX Therapeutics Inc Announces Launch Of XRX-026 Drug Development Program To Treat Gout
Brief: Xortx Strengthens Executive Team
Brief: XORTX Announces Closing Of $1.5 Million Registered Direct Offering And Concurrent Private Placement
Brief: XORTX Announces Pricing Of US$1.5 Million Registered Direct Offering And Concurrent Private Placement
Brief: Xortx Announces Us ATM Offering
Brief: Xortx Announces Share Consolidation
Brief: Xortx Therapeutics Inc Says Independent Proxy Firm, ISS, Recommends Shareholders Vote For Share Consolidation Resolution